Background pattern
RIVAROXABAN DR REDDYS 15 mg FILM-COATED TABLETS

RIVAROXABAN DR REDDYS 15 mg FILM-COATED TABLETS

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use RIVAROXABAN DR REDDYS 15 mg FILM-COATED TABLETS

Introduction

Package Leaflet: Information for the User

Rivaroxaban Dr. Reddys 15 mg film-coated tablets EFG

Rivaroxaban Dr. Reddys 20 mg film-coated tablets EFG

rivaroxaban

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack and other information

  1. What is Rivaroxaban Dr. Reddys and what is it used for
  2. What you need to know before you take Rivaroxaban Dr. Reddys
  3. How to take Rivaroxaban Dr. Reddys
  4. Possible side effects
  5. Storing Rivaroxaban Dr. Reddys
  1. Contents of the pack and further information

1. What is Rivaroxaban Dr. Reddys and what is it used for

Rivaroxaban Dr. Reddys contains the active substance rivaroxaban and is used in adults to:

  • prevent the formation of blood clots in the brain (stroke) or in other blood vessels of the body if you have a form of irregular heart rhythm called non-valvular atrial fibrillation.
  • treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), and to prevent these blood clots from happening again in the blood vessels of the legs and/or lungs.

Rivaroxaban Dr. Reddys is used in children and adolescents under 18 years of age and with a body weight of 30 kg or more to:

  • treat and prevent blood clots in the veins or in the blood vessels of the lungs after at least 5 days of initial treatment with injectable medicines used to treat blood clots.

Rivaroxaban Dr. Reddys belongs to a group of medicines called antithrombotic agents. It works by blocking a factor involved in blood clotting (factor Xa) and thus reducing the tendency of blood to form clots.

2. What you need to know before you take Rivaroxaban Dr. Reddys

Do not take Rivaroxaban Dr. Reddys

  • if you are allergic to rivaroxaban or any of the other ingredients of this medicine (listed in section 6)
  • if you have bleeding problems
  • if you have a disease or condition that increases the risk of serious bleeding (e.g. stomach ulcer, recent injury or bleeding in the brain, or recent brain or eye surgery)
  • if you are taking medicines to prevent blood clots (e.g. warfarin, dabigatran, apixaban or heparin), except when switching from one anticoagulant to another or when being treated with heparin through a venous or arterial catheter to prevent blockage
  • if you have a liver disease that increases the risk of bleeding
  • if you are pregnant or breast-feeding

Do not take Rivaroxaban Dr. Reddys and inform your doctorif any of these conditions apply to you.

Warnings and precautions

Consult your doctor or pharmacist before starting Rivaroxaban Dr. Reddys.

Be careful with Rivaroxaban Dr. Reddys

  • if you have an increased risk of bleeding, such as in the following situations:
  • severe kidney problems in adults and moderate or severe kidney disease in children and adolescents, as kidney function may affect the amount of medicine that works in your body
  • if you are taking other medicines to prevent blood clots (e.g. warfarin, dabigatran, apixaban or heparin), when switching to another anticoagulant or while receiving heparin through a venous or arterial catheter to prevent blockage (see section "Other medicines and Rivaroxaban Dr. Reddys")
  • bleeding disorders
  • very high blood pressure, not controlled by medical treatment
  • stomach or intestinal diseases that may cause bleeding, such as inflammation of the stomach or intestine, inflammation of the esophagus (throat), e.g. due to gastroesophageal reflux disease (a disease in which stomach acid rises up into the esophagus) or tumors located in the stomach or intestines or the genital or urinary tract
  • a problem in the blood vessels of the back of the eyes (retinopathy)
  • a lung disease in which the bronchi are dilated and filled with pus (bronchiectasis) or a previous lung hemorrhage
  • if you have a heart valve replacement
  • if you know you have a disease called antiphospholipid syndrome (a disorder of the immune system that increases the risk of blood clots), inform your doctor who will decide if it is necessary to change treatment.
  • if your doctor determines that your blood pressure is unstable or if you are scheduled to receive another treatment or undergo surgery to remove a blood clot from your lungs.

Tell your doctor if you have any of these conditionsbefore taking Rivaroxaban Dr. Reddys. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.

If you need surgery

  • It is very important to take Rivaroxaban Dr. Reddys before and after surgery, exactly at the times indicated by your doctor.
  • If your operation requires the insertion of a catheter or injection into the spine (e.g. for epidural or spinal anesthesia, or pain relief):
  • It is very important to take Rivaroxaban Dr. Reddys exactly at the times indicated by your doctor.
  • Tell your doctor immediately if you experience numbness or weakness in your legs or problems with your intestines or bladder after anesthesia, as urgent attention is needed.

Children and adolescents

Rivaroxaban Dr. Reddys is not recommended in children with a body weight below 30 kg.There is not enough information about the use of rivaroxaban in children and adolescents for the indications in adults.

Other medicines and Rivaroxaban Dr. Reddys

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, including those obtained without a prescription.

  • If you are taking
  • any medicine for a fungal infection (e.g. fluconazole, itraconazole, voriconazole, posaconazole), unless it is only applied to the skin
  • ketoconazole tablets (used to treat Cushing's syndrome, in which the body produces too much cortisol)
  • any medicine for bacterial infections (e.g. clarithromycin, erythromycin)
  • any antiviral medicine for HIV/AIDS (e.g. ritonavir)
  • other medicines to reduce blood clotting (e.g. enoxaparin, clopidogrel or vitamin K antagonists, such as warfarin or acenocoumarol)
  • anti-inflammatory medicines and pain relievers (e.g. naproxen or acetylsalicylic acid)
  • dronedarone, a medicine for the treatment of irregular heartbeat
  • certain medicines for the treatment of depression (selective serotonin reuptake inhibitors (SSRIs) or serotonin and norepinephrine reuptake inhibitors (SNRIs))

If any of the above circumstances apply to you, tell your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may increase. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.

If your doctor considers that you have a higher risk of developing stomach or intestinal ulcers, he/she will recommend that you also use a treatment to prevent ulcers.

  • If you are taking
  • any medicine for the treatment of epilepsy (phenytoin, carbamazepine, phenobarbital)
  • St. John's Wort (Hypericum perforatum), a herbal medicine for the treatment of depression
  • rifampicin, an antibiotic

If any of the above circumstances apply to you, tell your doctorbefore taking rivaroxaban, as the effect of Rivaroxaban Dr. Reddys may be reduced. Your doctor will decide if you should be treated with Rivaroxaban Dr. Reddys and if you should be kept under closer observation.

Pregnancy and breast-feeding

Do not take rivaroxaban if you are pregnant or breast-feeding. If there is a possibility that you may become pregnant, use a reliable contraceptive while taking rivaroxaban. If you become pregnant while taking this medicine, tell your doctor immediately, who will decide how you should be treated.

Driving and using machines

Rivaroxaban may cause dizziness (common side effect) or fainting (uncommon side effect) (see section 4, "Possible side effects"). You should not drive, ride a bicycle or use tools or machines if you are affected by these symptoms.

Rivaroxaban Dr. Reddys contains lactose and sodium

If your doctor has told you that you have an intolerance to some sugars, consult him/her before taking this medicine.

This medicine contains less than 1 mmol of sodium (23 mg) per tablet, i.e. it is essentially "sodium-free".

3. How to take Rivaroxaban Dr. Reddys

Follow exactly the instructions of administration of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

This medicine should be taken with food.

Swallow the tablet, preferably with water.

If you have difficulty swallowing the tablet whole, consult your doctor about other ways to take rivaroxaban. The tablet can be crushed and mixed with water or apple puree, immediately before taking it.

If necessary, your doctor may also administer the crushed rivaroxaban tablet through a gastric tube.

What dose to take

Adults

  • To prevent the formation of blood clots in the brain (stroke) or in other blood vessels.

The recommended dose is one rivaroxaban 20 mg tablet once a day.

If you have kidney problems, the dose may be reduced to one rivaroxaban 15 mg tablet once a day.

If you need to undergo a procedure to treat blocked blood vessels in your heart (called percutaneous coronary intervention - PCI with stent insertion), there is limited evidence to reduce the dose to one rivaroxaban 15 mg tablet once a day (or to one rivaroxaban 10 mg tablet once a day in case of impaired kidney function) in addition to an antiplatelet medicine such as clopidogrel.

  • To treat blood clots in the veins of the legs and in the blood vessels of the lungs, and to prevent these blood clots from happening again.

The recommended dose is one rivaroxaban 15 mg tablet twice a day for the first 3 weeks. For treatment after 3 weeks, the recommended dose is one Rivaroxaban 20 mg tablet once a day.

After at least 6 months of treatment for blood clots, your doctor may decide to continue treatment with one 10 mg tablet once a day or one 20 mg tablet once a day.

If you have kidney problems and are taking one Rivaroxaban 20 mg tablet once a day, your doctor may decide to reduce the treatment dose to one Rivaroxaban 15 mg tablet once a day after 3 weeks if the risk of bleeding is higher than the risk of having another blood clot.

Children and adolescents

The dose of rivaroxaban depends on body weight and will be calculated by the doctor.

  • The recommended dose for children and adolescents with a body weight between 30 kg and less than 50 kg is one rivaroxaban 15 mgtablet once a day.
  • The recommended dose for children and adolescents with a body weight of 50 kg or more is one rivaroxaban 20 mgtablet once a day.

Take each dose of rivaroxaban with a drink (e.g. water or juice) during a meal. Take the tablets every day at approximately the same time. Consider setting an alarm to remind you. For parents or caregivers: observe the child to ensure they take the full dose.

As the dose of rivaroxaban is based on body weight, it is important to attend scheduled medical visits because it may be necessary to adjust the dose as weight changes.

Never adjust the dose of rivaroxaban yourself. The doctor will adjust the dose if necessary.

Do not divide the tablet in an attempt to provide a fraction of the dose of a tablet. If a lower dose is required, use the alternative presentation of rivaroxaban granules for oral suspension. In the case of children and adolescents who cannot swallow whole tablets, use rivaroxaban granules for oral suspension.

If the oral suspension is not available, you can crush the rivaroxaban tablet and mix it with water or apple puree immediately before taking it. Take some food after taking this mixture. If necessary, your doctor may also administer the crushed rivaroxaban tablet through a gastric tube.

If you spit out the dose or vomit

  • less than 30 minutes after taking rivaroxaban, take a new dose.
  • more than 30 minutes after taking rivaroxaban, do not take a new dose. In this case, take the next dose of rivaroxaban at the usual time.

Contact your doctor if you spit out the dose or vomit repeatedly after taking rivaroxaban.

When to take Rivaroxaban Dr. Reddys

Take the tablet every day, until your doctor tells you to stop.

Try to take a tablet at the same time every day, to help you remember. The doctor will decide how long you should continue taking the treatment.

To prevent the formation of blood clots in the brain (stroke) or in other blood vessels:

If it is necessary to normalize your heartbeat through a procedure called cardioversion, take rivaroxaban at the time indicated by your doctor.

If you forget to take Rivaroxaban Dr. Reddys

Adults, children and adolescents:

  • If you are taking one 20 mg or one 15 mg tablet once a day and you miss a dose, take it as soon as you remember. Do not take more than one tablet in one day to make up for missed doses. Take the next tablet the next day and then continue taking one tablet once a day.

Adults:

  • If you are taking one 15 mg tablet twice a day and you miss a dose, take it as soon as you remember. Do not take more than two 15 mg tablets in one day. If you miss a dose, you can take two 15 mg tablets at the same time to get a total of two tablets (30 mg) in one day. The next day, continue taking one 15 mg tablet twice a day.

If you take more Rivaroxaban Dr. Reddys than you should

Contact your doctor immediately if you have taken too many rivaroxaban tablets. Taking too much rivaroxaban increases the risk of bleeding.

If you stop taking Rivaroxaban Dr. Reddys

Do not stop taking rivaroxaban without talking to your doctor first, because rivaroxaban prevents the development of a serious condition.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.

Like other similar medicines, to reduce the formation of blood clots, rivaroxaban can cause bleeding, which can put the patient's life at risk. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be evident.

Tell your doctor immediatelyif you or the child suffer from any of the following adverse effects:

Signs of bleeding

  • bleeding in the brain or inside the skull (symptoms may include headache, unilateral weakness, vomiting, seizures, decreased level of consciousness, and neck stiffness.

A serious medical emergency. Seek medical attention immediately!

  • prolonged or excessive bleeding
  • exceptional weakness, fatigue, paleness, dizziness, headache, unexplained swelling, difficulty breathing, chest pain or angina, as they may be signs of bleeding.

Your doctor will decide to keep you under closer observation or modify your treatment.

Signs of severe skin reaction:

Reactions

  • intense skin rashes that spread, blisters, or lesions on the mucous membranes, e.g., in the mouth or eyes (Stevens-Johnson syndrome/toxic epidermal necrolysis).
  • drug reaction that causes rash, fever, inflammation of internal organs, blood abnormalities, and systemic disease (DRESS syndrome).
  • The frequency of this adverse effect is very rare (up to 1 in 10,000 people).

Signs of severe allergic reaction:

  • swelling of the face, lips, mouth, tongue, or throat; difficulty swallowing; hives and difficulty breathing; sudden drop in blood pressure.

The frequencies of these adverse effects are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).

General list of possible adverse effects found in adults, children, and adolescents

Frequent(may affect up to 1 in 10 patients)

  • decrease in red blood cells that can cause paleness and weakness or difficulty breathing
  • bleeding from the stomach or intestine, urogenital hemorrhage (including blood in the urine and heavy menstrual bleeding), nasal bleeding, bleeding from the gums
  • bleeding in the eye (including bleeding in the white part of the eye)
  • bleeding into a tissue or cavity of the body (hematoma, bruising)
  • coughing up blood
  • bleeding from the skin or under the skin
  • bleeding after surgery
  • oozing of blood or fluid from a surgical wound
  • swelling of the limbs
  • pain in the limbs
  • alteration of kidney function (may be seen in tests performed by the doctor)
  • fever
  • stomach pain, indigestion, dizziness or feeling of dizziness, constipation, diarrhea
  • low blood pressure (symptoms may be dizziness or fainting when standing up)
  • general decrease in strength and energy (weakness, fatigue), headache, dizziness
  • rash, itching of the skin
  • blood tests may show an increase in some liver enzymes

Uncommon(may affect up to 1 in 100 patients)

  • bleeding in the brain or inside the skull (see above signs of bleeding)
  • bleeding into a joint, causing pain and swelling
  • thrombocytopenia (low platelet count, cells that help blood clotting)
  • allergic reaction, including skin allergic reaction
  • alteration of liver function (may be seen in tests performed by the doctor)
  • blood tests may show an increase in bilirubin, some pancreatic or liver enzymes, or platelet count
  • fainting
  • feeling of discomfort
  • increased heart rate
  • dry mouth
  • hives

Rare(may affect up to 1 in 1,000 patients)

  • bleeding into a muscle
  • cholestasis (decrease in bile flow), hepatitis, including traumatic hepatocellular injury (inflammation or liver damage)
  • yellowing of the skin and eyes (jaundice)
  • localized swelling
  • blood accumulation (hematoma) in the groin as a complication after heart surgery where a catheter is inserted into the leg artery (pseudoaneurysm)

Frequency not known(cannot be estimated from available data)

  • renal failure after severe bleeding.
  • increase in pressure in the muscles of the legs or arms after bleeding, causing pain, swelling, altered sensation, numbness, or paralysis (compartment syndrome due to bleeding)

Adverse effects in children and adolescents

In general, the adverse effects observed in children and adolescents treated with rivaroxaban were similar to those observed in adults and were mainly of mild to moderate severity.

Adverse effects that were more frequently observed in children and adolescents:

Very frequent(may affect more than 1 in 10 people)

  • headache
  • fever
  • nasal bleeding
  • vomiting

Frequent(may affect up to 1 in 10 people)

  • elevated heart rate
  • blood tests may show an increase in bilirubin (bile pigment)
  • thrombocytopenia (low platelet count, cells that help blood clotting)
  • heavy menstrual bleeding

Very rare(may affect up to 1 in 10,000 people)

  • accumulation of eosinophils, a type of white blood cell granulocytes that cause inflammation in the lung (eosinophilic pneumonia)

Uncommon(may affect up to 1 in 100 people)

  • blood tests may show an increase in a subcategory of bilirubin (direct bilirubin, bile pigment)

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Rivaroxaban Dr. Reddys

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date stated on the packaging and on each blister or bottle after "CAD" or "EXP". The expiration date is the last day of the month indicated.

This medicine does not require special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the pharmacy's SIGRE point. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Rivaroxaban Dr. Reddys

  • The active ingredient is rivaroxaban. Each tablet contains 15 mg and 20 mg of rivaroxaban.
  • The other ingredients are:

Core of the tablet: microcrystalline cellulose, lactose monohydrate, sodium croscarmellose, hypromellose, sodium lauryl sulfate, magnesium stearate. See section 2 "Rivaroxaban Dr. Reddys contains lactose and sodium"

Coating of the tablet: macrogol 3350, hypromellose, titanium dioxide (E 171), yellow iron oxide (E 172).

Appearance of the product and package contents

15 mg

They are red, round, biconvex (approximately 6 mm in diameter) and have a "15" engraved on one side.

They are packaged in blisters, in boxes of 10, 14, 28, 42, 98, or 100 film-coated tablets

20 mg

They are dark red, round, biconvex (approximately 6 mm in diameter) and have a "20" engraved on one side.

They are packaged in blisters, in boxes of 10, 14, 28, 42, 98, or 100 film-coated tablets

Only some package sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Reddy Pharma Iberia, S.A.

Avda. Josep Tarradellas nº 38

08029 Barcelona (Spain)

Phone: 93.355.49.16

Fax: 93.355.49.61

Manufacturer

Betapharm Arzneimittel GmbH

Kobelweg 95

86156 Augsburg

Germany

This medicine is authorized in the Member States of the European Economic Area under the following names:

Germany:

Rivaroxaban beta 15 mg Filmtabletten

Rivaroxaban beta 20 mg Filmtabletten

Betapharm Arzneimittel GmbH

Spain:

Rivaroxaban Dr. Reddys 15 mg

film-coated tablets EFG

Rivaroxaban Dr. Reddys 20 mg

film-coated tablets EFG

Reddy Pharma Iberia, S.A.

United Kingdom:

Rivaroxaban Dr. Reddy’s 15 mg Film-Coated Tablets

Rivaroxaban Dr. Reddy’s 20 mg Film-Coated Tablets

Dr. Reddy’s Laboratories (UK) Ltd.

Italy:

RIVAROXABAN DR. REDDY’S 15 mg

film-coated tablets

RIVAROXABAN DR. REDDY’S 20

mg film-coated tablets

Dr. Reddy’s S.r.l. Italy

Date of the last revision of this leaflet:September 2023

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe